Compare, Analyse ASTRAZENECA PHARMA with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs MYLAN (US) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   MYLAN
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
MYLAN
Dec-18
ASTRAZENECA PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,2783,410-   
Low Rs8831,877-   
Sales per share (Unadj.) Rs228.41,568.9-  
Earnings per share (Unadj.) Rs10.442.6-  
Cash flow per share (Unadj.) Rs16.3336.4-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs98.81,697.3-  
Shares outstanding (eoy) m25.00514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.71.7 280.8%   
Avg P/E ratio x104.262.0 168.0%  
P/CF ratio (eoy) x66.47.9 845.5%  
Price / Book Value ratio x10.91.6 702.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m27,0081,359,899 2.0%   
No. of employees `0001.435.0 3.9%   
Total wages/salary Rs m1,5350-   
Avg. sales/employee Rs Th4,210.923,062.8 18.3%   
Avg. wages/employee Rs Th1,132.20-   
Avg. net profit/employee Rs Th191.1626.3 30.5%   
INCOME DATA
Net Sales Rs m5,710807,198 0.7%  
Other income Rs m1230-   
Total revenues Rs m5,833807,198 0.7%   
Gross profit Rs m463208,873 0.2%  
Depreciation Rs m147151,139 0.1%   
Interest Rs m038,823 0.0%   
Profit before tax Rs m43818,910 2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m179-3,008 -5.9%   
Profit after tax Rs m25921,919 1.2%  
Gross profit margin %8.125.9 31.3%  
Effective tax rate %40.8-15.9 -256.7%   
Net profit margin %4.52.7 167.1%  
BALANCE SHEET DATA
Current assets Rs m3,209450,739 0.7%   
Current liabilities Rs m2,070328,638 0.6%   
Net working cap to sales %20.015.1 132.0%  
Current ratio x1.61.4 113.1%  
Inventory Days Days7284 86.6%  
Debtors Days Days3593 37.4%  
Net fixed assets Rs m790156,583 0.5%   
Share capital Rs m50430 11.6%   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,469873,241 0.3%   
Long term debt Rs m0942,508 0.0%   
Total assets Rs m4,6052,342,373 0.2%  
Interest coverage xNM1.5-  
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.20.3 359.8%   
Return on assets %5.62.6 217.0%  
Return on equity %10.52.5 418.0%  
Return on capital %17.73.2 557.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m88167,736 0.1%  
From Investments Rs m-94-86,701 0.1%  
From Financial Activity Rs mNA-78,141 0.0%  
Net Cashflow Rs m-61,390 -0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.63 Rs / USD

Compare ASTRAZENECA PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ASTRAZENECA PHARMA With: FDC LTD.  STRIDES PHARMA SCIENCE  ABBOTT INDIA  SUN PHARMA  WYETH LTD  



Today's Market

Slow Economy? There's Still Good Money to Be Made in the Markets(Podcast)

Indian stock markets mostly remained in the negative zone during the week except for Wednesday.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat Views On News (Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

Will Algo Traders Take Away All Your Profits? (Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

These Rebirth of India Stocks Are Raring to Compete with Tesla (The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
7 Stocks to Ride the Coming Rebirth of India Rally. Full Details Here...
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

ASTRAZENECA PHARMA SHARE PRICE


Feb 20, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS